Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Bone marrow findings in metastatic melanoma, including role of BRAF immunohistochemistry.

Corean JLE, George TI, Patel JL, Li KD.

Int J Lab Hematol. 2019 May 21. doi: 10.1111/ijlh.13051. [Epub ahead of print]

PMID:
31112348
2.

PD-L1 Expression in Mastocytosis.

Williams M, Lidke DS, Hartmann K, George TI.

Int J Mol Sci. 2019 May 13;20(9). pii: E2362. doi: 10.3390/ijms20092362. Review.

3.

The International Journal of Laboratory Hematology: 2007 to 2019.

Lee SH, George TI.

Int J Lab Hematol. 2019 May;41 Suppl 1:4-5. doi: 10.1111/ijlh.13002. No abstract available.

PMID:
31069970
4.

Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist.

Li P, Shahmarvand N, Lynch D, Gotlib JR, Merker JD, Zehnder JL, George TI, Ohgami RS.

Int J Lab Hematol. 2019 Jun;41(3):345-352. doi: 10.1111/ijlh.12981. Epub 2019 Feb 27.

PMID:
30811101
5.

The Neonatal Acute Bilirubin Encephalopathy Registry (NABER): Background, Aims, and Protocol.

Bahr TM, Christensen RD, Agarwal AM, George TI, Bhutani VK.

Neonatology. 2019;115(3):242-246. doi: 10.1159/000495518. Epub 2019 Jan 22.

PMID:
30669144
6.

Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).

Ustun C, Morgan E, Moodie EEM, Pullarkat S, Yeung C, Broesby-Olsen S, Ohgami R, Kim Y, Sperr W, Vestergaard H, Chen D, Kluin PM, Dolan M, Mrózek K, Czuchlewski D, Horny HP, George TI, Kristensen TK, Ku NK, Yi CA, Møller MB, Marcucci G, Baughn L, Schiefer AI, Hilberink JR, Pullarkat V, Shanley R, Kohlschmidt J, Coulombe J, Salhotra A, Soma L, Cho C, Linden MA, Akin C, Gotlib J, Hoermann G, Hornick J, Nakamura R, Deeg J, Bloomfield CD, Weisdorf D, Litzow MR, Valent P, Huls G, Perales MA, Borthakur G.

Cancer Med. 2018 Sep;7(9):4447-4455. doi: 10.1002/cam4.1733. Epub 2018 Aug 16.

7.

Multicenter evaluation of the cobas m 511 integrated hematology analyzer.

Bruegel M, George TI, Feng B, Allen TR, Bracco D, Zahniser DJ, Russcher H.

Int J Lab Hematol. 2018 Dec;40(6):672-682. doi: 10.1111/ijlh.12903. Epub 2018 Jul 20.

PMID:
30030894
8.

Patient Perceptions in Mast Cell Disorders.

Jennings SV, Slee VM, Zack RM, Verstovsek S, George TI, Shi H, Lee P, Castells MC.

Immunol Allergy Clin North Am. 2018 Aug;38(3):505-525. doi: 10.1016/j.iac.2018.04.006. Review.

9.

An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.

Sumarriva Lezama L, Chisholm KM, Carneal E, Nagy A, Cascio MJ, Yan J, Chang CC, Cherry A, George TI, Ohgami RS.

Histopathology. 2018 Nov;73(5):767-776. doi: 10.1111/his.13668. Epub 2018 Aug 6.

PMID:
29884995
10.

Acute neonatal bilirubin encephalopathy in the State of Utah 2009-2018.

Christensen RD, Agarwal AM, George TI, Bhutani VK, Yaish HM.

Blood Cells Mol Dis. 2018 Sep;72:10-13. doi: 10.1016/j.bcmd.2018.05.002. Epub 2018 May 23.

PMID:
29880417
11.

A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.

Margolskee E, Mikita G, Rea B, Bagg A, Zuo Z, Sun Y, Goswami M, Wang SA, Oak J, Arber DA, Allen MB, George TI, Rogers HJ, Hsi E, Hasserjian RP, Orazi A.

Mod Pathol. 2018 Jun;31(6):873-880. doi: 10.1038/s41379-018-0001-2. Epub 2018 Feb 5.

12.

Variability of PD-L1 expression in mastocytosis.

Hatch EW, Geeze MB, Martin C, Salama ME, Hartmann K, Eisenwort G, Blatt K, Valent P, Gotlib J, Lee JH, Chen L, Ward HH, Lidke DS, George TI.

Blood Adv. 2018 Feb 13;2(3):189-199. doi: 10.1182/bloodadvances.2017011551.

13.

T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group.

Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, Morice WG, Zhang QY, George TI, Foucar KK, Bhattacharyya S, Bagg A, Rogers HJ, Bodo J, Durkin L, Hsi ED.

Am J Clin Pathol. 2018 Jan 29;149(2):164-171. doi: 10.1093/ajcp/aqx146.

PMID:
29365010
14.

Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal.

Valent P, Akin C, Arock M, Bock C, George TI, Galli SJ, Gotlib J, Haferlach T, Hoermann G, Hermine O, Jäger U, Kenner L, Kreipe H, Majeti R, Metcalfe DD, Orfao A, Reiter A, Sperr WR, Staber PB, Sotlar K, Schiffer C, Superti-Furga G, Horny HP.

EBioMedicine. 2017 Dec;26:17-24. doi: 10.1016/j.ebiom.2017.11.024. Epub 2017 Nov 26. Review.

15.

Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists.

George TI, Tworek JA, Thomas NE, Fatheree LA, Souers RJ, Nakhleh RE, Arber DA.

Arch Pathol Lab Med. 2017 Aug;141(8):1101-1106. doi: 10.5858/arpa.2016-0398-CP. Epub 2017 May 24.

PMID:
28537804
16.

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.

Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos CE, Arber DA, Verstovsek S, Orazi A.

Haematologica. 2017 Aug;102(8):1352-1360. doi: 10.3324/haematol.2017.165340. Epub 2017 May 11.

17.

Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.

Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP.

Am J Clin Pathol. 2017 Apr 1;147(4):411-419. doi: 10.1093/ajcp/aqx020.

PMID:
28375434
18.

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD.

Cancer Res. 2017 Mar 15;77(6):1261-1270. doi: 10.1158/0008-5472.CAN-16-2234. Epub 2017 Mar 2. Review.

19.

A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.

Gars E, Yousry SM, Babu D, Kurzer JH, George TI, Gratzinger D.

Leuk Lymphoma. 2017 Jul;58(7):1730-1732. doi: 10.1080/10428194.2016.1251590. Epub 2016 Nov 3. No abstract available.

PMID:
27808583
20.

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.

Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H.

BMC Cancer. 2016 Aug 19;16:652. doi: 10.1186/s12885-016-2710-6.

Supplemental Content

Loading ...
Support Center